MorphoSys Completes Enrollment in MOR103 Phase 1b/2a RA Trial

News   Aug 28, 2012

 
MorphoSys Completes Enrollment in MOR103 Phase 1b/2a RA Trial
 
 
 
FURTHER INFORMATION
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE